Live from the NIH registry
Studies recruiting near Evansville right now
Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Owensboro Medical Health System ( Site 0066) — Owensboro, Kentucky (27.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Phase 3
Interventional 830 participants sought
Research Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: AstraZeneca
Persona Revision Knee System Outcomes
Arthroplasty Complications, Infection
N/A
Observational 380 participants sought
Orthopaedic Associates, Inc. — Evansville, Indiana (1.5 mi)
· Sponsor: Zimmer Biomet
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Osteoarthritis, Overweight or Obesity
Phase 3
Interventional 900 participants sought
Qualmedica Research, LLC — Evansville, Indiana (1.5 mi)
· Sponsor: Eli Lilly and Company
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
Phase 3
Interventional 292 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: GlaxoSmithKline
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Asthma
Phase 2
Interventional 69 participants sought
Research Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: AstraZeneca
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: BeOne Medicines
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: NRG Oncology
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Tophaceous Gout
Phase 3
Interventional 250 participants sought
MediSphere Medical Research Center, LLC - East — Evansville, Indiana (1.5 mi)
· Sponsor: Crystalys Therapeutics
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Phase 3
Interventional 1,205 participants sought
Deaconess Clinic- Gateway — Newburgh, Indiana (7.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Asthma
Phase 2
Interventional 531 participants sought
Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky (27.3 mi)
· Sponsor: Eli Lilly and Company
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9915 — Evansville, Indiana (1.5 mi)
· Sponsor: Anthos Therapeutics, Inc.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Evansville, Indiana (1.5 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
MediSphere Medical Research Center, LLC — Evansville, Indiana (1.5 mi)
· Sponsor: Crystalys Therapeutics
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Kenney Orthopedics - Evansville — Evansville, Indiana (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: NRG Oncology
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Pain
N/A
Observational 4,800 participants sought
Global Scientific Innovations - Advanced Pain Care Clinic — Evansville, Indiana (1.5 mi)
· Sponsor: Boston Scientific Corporation
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Cardiovascular Disease
Phase 3
Interventional 11,000 participants sought
MediSphere Medical Research Center LLC — Evansville, Indiana (1.5 mi)
· Sponsor: Amgen
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Deaconess GI Specialty Center — Newburgh, Indiana (7.6 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Obesity, Overweight and/or Obesity
Phase 3
Interventional 954 participants sought
MediSphere Medical Research Center, LLC — Evansville, Indiana (1.5 mi)
· Sponsor: Pfizer
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Deaconess Clinic - GI Specialty Center — Newburgh, Indiana (7.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Evansville, Indiana (1.5 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Evansville, Indiana (1.5 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Wheezing, Asthma
Phase 3
Interventional 90 participants sought
Allergy and Asthma Specialist- Site Number : 8400002 — Owensboro, Kentucky (27.3 mi)
· Sponsor: Sanofi